Combination pegylated interferon alpha-2b and ribavirin in transplant patients with recurrent hepatitis C infection: A preliminary report.

被引：0
|
作者：
Vargas, HE [1 ]
Rosati, MJ [1 ]
Douglas, DD [1 ]
Harrison, ME [1 ]
Mulligan, DC [1 ]
Moss, AA [1 ]
Rakela, J [1 ]
Balan, V [1 ]
机构：
[1] Mayo Clin, Phoenix, AZ USA
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
939
引用
收藏
页码：407A / 407A
页数：1
相关论文
共 50 条
  • [31] Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT
    Jacobson, IM
    Ahmed, F
    Russo, MW
    Lebovics, E
    Dieterich, DI
    Esposito, SP
    Bach, N
    Klion, F
    Tobias, H
    Antignano, L
    Brown, RS
    Gabbaizadeh, D
    Geders, J
    Levendoglu, H
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (09): : 1700 - 1705
  • [32] Acute Hepatitis C: A 24-Week Course of Pegylated Interferon Alpha-2b Versus a 12-Week Course of Pegylated Interferon Alpha-2b Alone or With Ribavirin
    Santantonio, Teresa
    Fasano, Massimo
    Sagnelli, Evangelista
    Tundo, Paolo
    Babudieri, Sergio
    Fabris, Paolo
    Toti, Mario
    Di Perri, Giovanni
    Marino, Nicoletta
    Pizzigallo, Eligio
    Angarano, Gioacchino
    [J]. HEPATOLOGY, 2014, 59 (06) : 2101 - 2109
  • [33] Pegylated interferon alpha-2a (Pegasys) versus pegylated interferon alpha-2b (Pegintron) in the treatment of chronic hepatitis C infection
    Anees, MR
    Reddymasu, S
    Bejjanki, HR
    Caldito, G
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S142 - S142
  • [34] Preemptive therapy with pegylated interferon alpha-2b and ribavirin after liver transplantation for hepatitis C cirrhosis
    Castedal, M
    Felldin, M
    Bäckman, L
    Olausson, M
    Friman, S
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (08) : 3313 - 3314
  • [35] Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues - Reply
    Kamal, Sanaa
    Schardell, Michelle
    El Kamary, Samer
    Hashem, Mohamed
    Mansour, Hoda
    Ibrahim, Amany Sayed
    [J]. HEPATOLOGY, 2008, 47 (05) : 1793 - 1794
  • [36] Reduction of hepatocellular carcinoma recurrence by pegylated interferon alpha-2b plus ribavirin treatment for chronic hepatitis C patients
    Furusyo, N.
    Murata, M.
    Ogawa, E.
    Nomura, H.
    Hayashi, J.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S130 - S130
  • [37] The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin
    Ogawa, Eiichi
    Furusyo, Norihiro
    Toyoda, Kazuhiro
    Takeoka, Hiroaki
    Maeda, Shinji
    Hayashi, Jun
    [J]. ANTIVIRAL RESEARCH, 2009, 83 (02) : 127 - 134
  • [38] Pegylated interferon therapy with/without ribavirin in liver transplant recipients with recurrent hepatitis C infection
    Levitsky, J
    Cohen, SM
    Dasgupta, KA
    Faust, TW
    Te, HS
    [J]. HEPATOLOGY, 2002, 36 (04) : 182A - 182A
  • [39] IMPACT OF PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT ON GRAFT SURVIVAL IN LIVER TRANSPLANT PATIENTS WITH RECURRENT HEPATITIS C INFECTION
    Veldt, B. J.
    Poterucha, J. J.
    Watt, K. D. S.
    Weisner, R. H.
    Hay, J. E.
    Kremers, W. K.
    Rosen, C. B.
    Heimbach, J. K.
    Charlton, M. R.
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S183 - S183
  • [40] Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection
    Veldt, B. J.
    Poterucha, J. J.
    Watt, K. D. S.
    Wiesner, R. H.
    Hay, J. E.
    Kremers, W. K.
    Rosen, C. B.
    Heimbach, J. K.
    Charlton, M. R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (11) : 2426 - 2433
12345